Ambroxol, a common cough medicine, may help stabilize neuropsychiatric symptoms in Parkinson’s disease dementia (PDD) and shows cognitive promise for…
Articles by Lila Levinson, PhD
Genetic analysis of saliva may offer a noninvasive way to assess the risk of developing Parkinson’s disease, according to…
Note: This story was updated Oct. 7, 2025, to correct the headline and first paragraph to reflect that while Pharmather…
BioVie’s ongoing SUNRISE-PD clinical trial of bezisterim in early Parkinson’s disease uses a hybrid, decentralized approach to center patient…
Neuron23 has dosed the first participant in its Phase 2 clinical trial of NEU-411, an investigational treatment for early…
A new method that uses artificial intelligence (AI) to analyze the smell of earwax may help detect Parkinson’s disease,…
A new clinical program will use ibogaine, a naturally occurring psychedelic, to treat neurodegenerative conditions including Parkinson’s disease.
CAP-003, a gene therapy for Parkinson’s disease associated with GBA mutations, has been cleared by the U.S. Food and Drug…
Parkinson’s disease patients in a pilot study testing the effects of equine-associated therapy report that they enjoy working with…
Barriers including physical difficulties and social stigma may affect how people with Parkinson’s disease use assistive devices meant to…